Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
Barnes and the Schizophrenia Consensus Group of the British A
J Psychopharmacol 2011;25:567-620.
ABSTRACT
| FULL TEXT
Long-term Antipsychotic Treatment and Brain Volumes: A Longitudinal Study of First-Episode Schizophrenia
Ho et al.
Arch Gen Psychiatry 2011;68:128-137.
ABSTRACT
| FULL TEXT
Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial
Chen et al.
BMJ 2010;341:c4024-c4024.
ABSTRACT
| FULL TEXT
Formulation Optimization of Long-acting Depot Injection of Aripiprazole by Using D-optimal Mixture Design
Nahata and Saini
PDA J Pharm Sci Technol 2009;63:113-122.
ABSTRACT
| FULL TEXT
Clinical Recovery in First-Episode Psychosis
Wunderink et al.
Schizophr Bull 2009;35:362-369.
ABSTRACT
| FULL TEXT
Continued Controversies: Issues in Mental Health Research and Implications for Nursing
Spath
J Am Psychiatr Nurses Assoc 2007;13:221-229.
ABSTRACT
Schizophrenia in Translation: Is Active Psychosis Neurotoxic?
McGlashan
Schizophr Bull 2006;32:609-613.
ABSTRACT
| FULL TEXT
Medication-Free Research in Early Episode Schizophrenia: Evidence of Long-Term Harm?
Bola
Schizophr Bull 2006;32:288-296.
ABSTRACT
| FULL TEXT
Can Medication-Free Research Ever Be Ethical in Older People With Psychotic Disorders?
Jeste
Schizophr Bull 2006;32:303-304.
FULL TEXT
Lifetime suicide rates in treated schizophrenia: 1875-1924 and 1994-1998 cohorts compared
HEALY et al.
Br. J. Psychiatry 2006;188:223-228.
ABSTRACT
| FULL TEXT
A Summary of Important Documents in the Field of Research Ethics
Fischer
Schizophr Bull 2006;32:69-80.
ABSTRACT
| FULL TEXT
Control Group Bias in Randomized Atypical Antipsychotic Medication Trials for Schizophrenia
Woods et al.
Arch Gen Psychiatry 2005;62:961-970.
ABSTRACT
| FULL TEXT
Clinical Utilization of Atypical Antipsychotics in Pregnancy and Lactation
Gentile
The Annals of Pharmacotherapy 2004;38:1265-1271.
ABSTRACT
| FULL TEXT
Progressive Structural Brain Abnormalities and Their Relationship to Clinical Outcome: A Longitudinal Magnetic Resonance Imaging Study Early in Schizophrenia
Ho et al.
Arch Gen Psychiatry 2003;60:585-594.
ABSTRACT
| FULL TEXT
The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England
Biswas et al.
J Psychopharmacol 2001;15:265-271.
ABSTRACT
Treatment of schizophrenia
Bracken et al.
BMJ 2000;320:800-800.
FULL TEXT
Best Practice Outcomes for Schizophrenia: Does Measurement of Medication Compliance Provide a Key?
Thomas
Australas Psychiatry 1998;6:306-308.
Six-Month Outcome following a Relapse of Schizophrenia
Bergen et al.
Aust N Z J Psychiatry 1998;32:815-822.
ABSTRACT
Neuroleptic Management of Schizophrenia: A Survey and Commentary on Australian Psychiatric Practice
Parker et al.
Aust N Z J Psychiatry 1998;32:50-58.
ABSTRACT
Delayed Normalization of Central D2 Dopamine Receptor Availability After Discontinuation of Haloperidol Decanoate: Preliminary Findings
Nyberg et al.
Arch Gen Psychiatry 1997;54:953-958.
ABSTRACT
The Rationale and Ethics of Medication-Free Research in Schizophrenia
Carpenter et al.
Arch Gen Psychiatry 1997;54:401-407.
ABSTRACT
Medication-Free Research With Schizophrenic Patients: A European Perspective
Henn et al.
Arch Gen Psychiatry 1997;54:412-413.
ABSTRACT
Choosing an Antipsychotic in the reatment of Schizophrenia: Conversions to Olanzapine
Littrell and Littrell
J Am Psychiatr Nurses Assoc 1997;3:S18-S23.
ABSTRACT
Clinical Risk Following Abrupt and Gradual Withdrawal of Maintenance Neuroleptic Treatment
Viguera et al.
Arch Gen Psychiatry 1997;54:49-55.
ABSTRACT
Conversions From Clozapine to Other Antipsychotic Drugs
Baldessarini et al.
Arch Gen Psychiatry 1995;52:1071-1072.
ABSTRACT
Neuroleptic Treatment of Agitation and Psychosis in Dementia
Devanand and Levy
J Geriatr Psychiatry Neurol 1995;8:S18-S27.
ABSTRACT
Risk of Tardive Dyskinesia in Older Patients: A Prospective Longitudinal Study of 266 Outpatients
Jeste et al.
Arch Gen Psychiatry 1995;52:756-765.
ABSTRACT
Discontinuing Neuroleptics in Schizophrenics: Good News or Bad News?
JWatch Psychiatry 1995;1995:1-1.
FULL TEXT
Neuroleptic Withdrawal in Schizophrenic Patients
Baldessarini et al.
Arch Gen Psychiatry 1995;52:189-192.
ABSTRACT
Why Neuroleptic Withdrawal in Schizophrenia?
Carpenter and Tamminga
Arch Gen Psychiatry 1995;52:192-193.
ABSTRACT
Long-term Treatment for Lifetime Disorders?
Greden and Tandon
Arch Gen Psychiatry 1995;52:197-200.
ABSTRACT
Neuroleptic Withdrawal in Schizophrenic Patients: An Idea Whose Time Has Come
Meltzer
Arch Gen Psychiatry 1995;52:200-202.
ABSTRACT
The Early Course of Schizophrenia and Long-term Maintenance Neuroleptic Therapy
Nuechterlein et al.
Arch Gen Psychiatry 1995;52:203-205.
ABSTRACT
Risks of Withdrawing Antipsychotic Medications
Wyatt
Arch Gen Psychiatry 1995;52:205-208.
ABSTRACT
Considering Neuroleptic Maintenance and Taper on a Continuum: Need for Individual Rather Than Dogmatic Approach
Jeste et al.
Arch Gen Psychiatry 1995;52:209-212.
ABSTRACT
